Clinical Trial Details

< Previous Trial     Next Trial >
Study ID PETMR-Prostate
Investigator
Jeong Yeon Cho, MD,   Seoul National University Hospital
Title Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer
Conditions Prostate Cancer Recurrent
Stage II Prostate Carcinoma
Stage III Prostate Carcinoma
Interventions Device: PET/MR
Phase N/A
Purpose To development of clinical assessment technique using multi-radiotracer positron emission tomography/magnetic resonance (PET/MR) in prostate cancer - to establish the optimal imaging technique of PET/MR using multiple radioactive tracers for prostate cancer - to establish the imaging biomarker using PET/MR for clinical assessment of prostate cancer and early detection of recurrent prostate cancer
Eligibility Ages Eligible: N/A
Genders Eligible:  Male
Accepts Healthy Volunteers:  No
Inclusion Criteria:
  • patient with prostate cancer before treatment
  • patient with prostate cancer treated
  • patient with prostate cancer recurrent
Exclusion Criteria:
  • patient with contraindication for MRI
  • Patient with severe renal impairment
Study Location
Contact

Information objtained from ClinicalTrials.gov, on 4/23/2014. For additional information about this and other clinical trials, visit http://clinicaltrials.gov.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01938339


Back to Search Results